Differential regulation of p27kip1 levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells
- 20 January 1999
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1448 (3) , 525-532
- https://doi.org/10.1016/s0167-4889(98)00149-9
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Arresting developments in cell-cycle controlTrends in Biochemical Sciences, 1994
- Mammalian G1 cyclinsCell, 1993
- Angiotensin II‐induced vascular smooth muscle cell hypertrophy: PDGF A‐chain mediates the increase in cell sizeJournal of Cellular Physiology, 1993
- Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cellsBiochemical and Biophysical Research Communications, 1992
- Association of human cyclin E with a periodic G1-S phase protein kinaseScience, 1992
- Formation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell CycleScience, 1992
- Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.Journal of Clinical Investigation, 1989
- Angiotensin II Induces c-fos mRNA in Aortic Smooth MuscleJournal of Biological Chemistry, 1989
- Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.Circulation Research, 1988
- Amiloride sensitive activation of S6 kinase by angiotensin II in cultured vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1988